About this event
In this FREE 60-minute Live Panel discussion, the UK’s leading NHS commentators join us to keep you on top of the changing NHS across the UK.
Ian Chamberlain is joined by a panel of experts to take an in-depth look at how the Celtic Nations are progressing in the current environment of winter pressures, the COVID-19 aftermath, delayed bed discharges and NHS strikes. Our panellists look at the impact of the increasing waiting lists across the healthcare systems, the importance of relevant data gathering to support product applications and why value proposition needs to be aligned with current healthcare strategies.
Hosted by
Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.
Brenda founded AXIS Consulting over 10 years ago to provide highly personalised customer service to internationally based clients. Her team at AXIS are firmly committed to working closely with each and every one of our clients to understand their priorities and help resolve the issues being faced.
Andrew is a highly experienced Global Market Access expert, leading pragmatic, solution focussed consultancy services at Initiate, a best-in-class consultancy with exceptional experience in the rare disease sector. Having gained initial experience in field-based and market-access commercial roles, his career moved into senior management roles leading HTA submissions, pricing and reimbursement projects, Value Dossier development, and Value Communication across global markets. Andrew has a unique set of experience, developing and implementing access initiatives with a particular focus on launching new products in the rare disorder arena. His focus is primarily to ensure clinical demand, value demonstration, and acceptance by the payer customer group independent of their market, data set, and belief.
Payer, Clinician and Decision Maker Market Research Insight interviews and reporting to support pre-market activities and launch plans. Asset evaluation of new entities or innovations to inform acquisition or market preparation. Pharmaceutical, Medtech, Life-science / Healthcare tools or innovations Sarah represents ABPI companies on the AWTTC Industry Forum.
Tim has worked in the Pharma industry for 35 years, 32 years of which have been with GSK. His career to date has spanned every conceivable role in the field. Based in Belfast Northern Ireland he has worked throughout the UK and Ireland, and as a result, his network is vast. He is a highly respected and credible individual with high-value relationships earned in Market Access activities and Government Affairs with many NI healthcare stakeholders He has achieved a portfolio of market access successes as a result of understanding the intricacies and networks of healthcare in Northern Ireland. Whilst leading GSK’s account management approach to NI Medicines Management he delivered successes across nine different therapy areas He was also a member of the ABPI NI Leadership team
Tony has worked in and around the pharma industry for 20+ years with 15 years in the client environment and the last 10 in the consultancy side. He has a passion for Real World Data and increasing its effective utilisation for patient benefit. Innovating new solutions is another passion and he carries a wealth of experience across multiple disease areas and pharmaceutical organisations. Tony is an expert on Patient Identification and complex HES analyses.
LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.